Jian Ming

727 total citations
39 papers, 379 citations indexed

About

Jian Ming is a scholar working on Economics and Econometrics, Cardiology and Cardiovascular Medicine and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Jian Ming has authored 39 papers receiving a total of 379 indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Economics and Econometrics, 6 papers in Cardiology and Cardiovascular Medicine and 5 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Jian Ming's work include Health Systems, Economic Evaluations, Quality of Life (17 papers), Pharmaceutical Economics and Policy (8 papers) and Blood Pressure and Hypertension Studies (3 papers). Jian Ming is often cited by papers focused on Health Systems, Economic Evaluations, Quality of Life (17 papers), Pharmaceutical Economics and Policy (8 papers) and Blood Pressure and Hypertension Studies (3 papers). Jian Ming collaborates with scholars based in China, United States and Canada. Jian Ming's co-authors include Yanfang Wang, Wen Chen, Luying Zhang, Yihao Tian, Yingyao Chen, Xueshan Qiu, Raymond Pong, Yi Yang, Lizheng Shi and Yan Wei and has published in prestigious journals such as BMJ, Carbohydrate Polymers and Frontiers in Immunology.

In The Last Decade

Jian Ming

35 papers receiving 376 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jian Ming China 10 162 49 45 45 41 39 379
Susan Knox United Kingdom 8 86 0.5× 38 0.8× 61 1.4× 29 0.6× 27 0.7× 20 646
E. W. Boeschoten Netherlands 11 129 0.8× 15 0.3× 44 1.0× 28 0.6× 30 0.7× 13 717
Titilayo O. Ilori United States 11 55 0.3× 27 0.6× 29 0.6× 20 0.4× 67 1.6× 26 410
Olivera Stojceva-Taneva North Macedonia 11 88 0.5× 43 0.9× 16 0.4× 35 0.8× 59 1.4× 41 447
Zhanhao Su China 13 98 0.6× 33 0.7× 49 1.1× 24 0.5× 156 3.8× 34 561
Mehdi Aloosh Canada 12 76 0.5× 37 0.8× 16 0.4× 53 1.2× 20 0.5× 32 365
Hyeonyoung Ko South Korea 11 59 0.4× 54 1.1× 37 0.8× 14 0.3× 29 0.7× 31 354
Lorna Murphy United States 9 120 0.7× 20 0.4× 53 1.2× 10 0.2× 17 0.4× 16 408
Jeetvan Patel United States 13 179 1.1× 43 0.9× 80 1.8× 126 2.8× 62 1.5× 25 473
Tomoya Myojin Japan 14 55 0.3× 34 0.7× 41 0.9× 24 0.5× 78 1.9× 53 427

Countries citing papers authored by Jian Ming

Since Specialization
Citations

This map shows the geographic impact of Jian Ming's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jian Ming with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jian Ming more than expected).

Fields of papers citing papers by Jian Ming

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jian Ming. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jian Ming. The network helps show where Jian Ming may publish in the future.

Co-authorship network of co-authors of Jian Ming

This figure shows the co-authorship network connecting the top 25 collaborators of Jian Ming. A scholar is included among the top collaborators of Jian Ming based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jian Ming. Jian Ming is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Chen, Yuanyuan, Qian Zhou, Yue Zhou, et al.. (2025). Premna microphylla Turcz pectin-modified diosmetin nanoparticles: A galectin-3 targeting strategy for precise colitis intervention. Carbohydrate Polymers. 368(Pt 1). 124067–124067.
2.
Zhang, Xuliang, et al.. (2024). Wild-Type p53 Regulates Apoptosis of Human Breast Cancer Cells. Discovery Medicine. 36(191). 2445–2445. 2 indexed citations
3.
Liu, Shimeng, et al.. (2024). Mapping of health technology assessment in China: a comparative study between 2016 and 2021. Global Health Research and Policy. 9(1). 4–4. 1 indexed citations
4.
Ming, Jian, Hang Zhao, Xin Zeng, & Ronghui Zhou. (2024). Colorimetric sensing of oral cancer overexpressed 1 gene in saliva samples with a low-background G-quadruplex DNAzyme probe. Microchemical Journal. 208. 112474–112474. 1 indexed citations
5.
Liu, Liu, Fuming Li, Yi Yang, et al.. (2024). A systematic review on reporting quality of economic evaluations for negotiated glucose-lowering drugs in China national reimbursement drug list. BMC Health Services Research. 24(1). 562–562.
6.
Ming, Jian, et al.. (2024). Cost-effectiveness of Finerenone in Addition to Standard of Care for Patients with Chronic Kidney Disease and Type 2 Diabetes in China. Advances in Therapy. 41(8). 3138–3158. 4 indexed citations
7.
Wu, Jing, Jian Ming, Shuli Qu, et al.. (2023). HPR51 Should Volume-Based Procurement Price of Comparator be Referenced for Innovative Drugs in National Reimbursement Drug List Negotiation in China?. Value in Health. 26(6). S220–S220. 1 indexed citations
10.
Tian, Yihao & Jian Ming. (2022). The role of circadian rhythm in osteoporosis; a review. Frontiers in Cell and Developmental Biology. 10. 960456–960456. 13 indexed citations
11.
Chung, Hsing‐Yi, Jian Ming, Chih-Kai Chang, et al.. (2022). The application of a novel 5-in-1 multiplex reverse transcriptase–polymerase chain reaction assay for rapid detection of SARS-CoV-2 and differentiation between variants of concern. International Journal of Infectious Diseases. 127. 56–62.
12.
Zhao, Xinran, Jian Ming, Shuli Qu, et al.. (2021). Cost-Effectiveness of Flash Glucose Monitoring for the Management of Patients with Type 1 and Patients with Type 2 Diabetes in China. Diabetes Therapy. 12(12). 3079–3092. 13 indexed citations
13.
Ming, Jian, et al.. (2021). Clinical Perspectives on the Use of Different Peripheral Intravenous Catheters with the Implementation of Volume-based Procurement in China. Science Journal of Public Health. 9(2). 49–49. 1 indexed citations
14.
Zhang, Qingfu, Yunan Han, Yao Zhang, et al.. (2021). Treatment-Emergent Neuroendocrine Prostate Cancer: A Clinicopathological and Immunohistochemical Analysis of 94 Cases. Frontiers in Oncology. 10. 571308–571308. 24 indexed citations
17.
Xu, Yan, et al.. (2019). Cost-Effectiveness Analysis of Non-invasive Prenatal Testing for Down Syndrome in China. International Journal of Technology Assessment in Health Care. 35(3). 237–242. 12 indexed citations
19.
Wang, Yanfang, et al.. (2018). Disease burden of COPD in China: a systematic review. International Journal of COPD. Volume 13. 1353–1364. 179 indexed citations
20.
Zhang, Qingfu, Jian Ming, Siyang Zhang, et al.. (2014). Micropapillary component in gastric adenocarcinoma: an aggressive variant associated with poor prognosis. Gastric Cancer. 18(1). 93–99. 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026